Ireland
--:--IST
Priya Life Science Sponsor trial record
Sponsor · clinical trials

European University Miguel de Cervantes clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our Spain register with European University Miguel de Cervantes as lead sponsor. Synced 14 Nov 2026
6Current trials
4Recruiting now
0Drugs in these trials
1Trial register
At a glance

European University Miguel de Cervantes is the lead sponsor of 6 current clinical trials in our Spain register. 4 are recruiting patients now. The most common phase is Not applicable. The most-studied condition is Frailty.

ClinicalTrials.gov trials by status

  • Recruiting467%
  • Not yet open233%

Trials by phase

  • Not applicable583%
  • Observational117%
01

Clinical trials sponsored by European University Miguel de Cervantes

6 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
Acute Effects of High-intensity Interval Aerobic and Functional Training at Different Intensities
NCT07180550 · ClinicalTrials.gov ↗ · High Intensity Interval Training (Cycling), High Intensity Interval Training (Running), High Intensity Functional Training
Not applicable Recruiting 2025-10 Spain
Life Monitoring for Rural Older Adults
NCT06974006 · ClinicalTrials.gov ↗ · Aged 60 Years or Older
Observational Recruiting 2025-05 Spain
Impact of Prehabilitation and Comprehensive Follow-up in Women With Breast Cancer
NCT07467824 · ClinicalTrials.gov ↗ · Breast Cancer, Breast Neoplasms
Not applicable Recruiting 2026-04 Spain
Effects of a Isokinetic Exercise in Women With Fibromyalgia
NCT07483216 · ClinicalTrials.gov ↗ · Fibromyalgia (FM)
Not applicable Recruiting 2026-04 Spain
Multicomponent Exercise and Virtual Reality for Older Adults
NCT07529743 · ClinicalTrials.gov ↗ · Frailty, Aging, Functional Impairment
Not applicable Not yet open 2026-04 Spain
Exercise in Alzheimer's Disease: Functional Biomarkers
NCT07918417 · ClinicalTrials.gov ↗ · Alzheimer's Dementia (AD), Alzheimer Disease (AD)
Not applicable Not yet open 2026-11 Spain

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Conditions in European University Miguel de Cervantes trials

13 conditions
Frailty1Aging1Functional Impairment1High Intensity Interval Training (Cycling)1High Intensity Interval Training (Running)1High Intensity Functional Training1Moderate Intensity Functional Training1Aged 60 Years or Older1Breast Cancer1Breast Neoplasms1Alzheimer's Dementia (AD)1Alzheimer Disease (AD)1Fibromyalgia (FM)1
03

By trial register

RegisterTrialsRecruiting
Clinical trials in Spain64

A trial with sites in more than one country appears in each of those registers.

04

Other sponsors in Frailty

SponsorTrials
University of Limerick3
National University of Singapore2
Fundacion Miguel Servet2
Universidad de Burgos2
Tomas Bata Hospital, Czech Republic2
Konya City Hospital2
Tata Medical Center1
Lanyue Zhu1
Yongtao Sun1
FengYan Jin1

Sponsors with the most current trials registered for this condition.

05

Questions about European University Miguel de Cervantes trials

How many clinical trials does European University Miguel de Cervantes sponsor?

European University Miguel de Cervantes is the lead sponsor of 6 current trials on ClinicalTrials.gov in our Spain register, as of the registry sync on 14 November 2026. Completed and withdrawn studies are not counted.

Are European University Miguel de Cervantes trials recruiting?

Yes. 4 of its 6 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 14 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.